M PQT/MED reliance on the work of national regulatory agencies and regional regulatory systems – new pathways PDF Guideline/guidance
M PQT/MED-specific Annotations for the WHO guideline on Biopharmaceutics Classification System-based biowaivers PDF Guideline/guidance
M Préqualification des laboratories de contrôle de qualité. Procédure d'evaluation de l'acceptabilité, de principe, des laboratoires de contrôle qualité à l'usage des institutions des Nations Unies PDF Guideline/guidance
M Principles for prioritizing dossiers within the WHO Prequalification Team: medicines (27 October 2011) PDF Information note
M Procedure to enable national registration of products prequalified based on SRA approval through CRP-18-March-2025 PDF Guideline/guidance
M Procedure to enable prequalification products approved by SRAs for use outside the SRA region-18 March 2025 PDF Guideline/guidance
M Product Recall - Moxifloxacin 100mg Dispersible Tablets (TB342): Batch BMC5801A PDF Information note
M Public consultation on proposed financing model for WHO prequalification: summary of responses received Application form
M Public consultation on proposed financing model for WHO prequalification: summary of responses received (issued 2 June 2015) PDF Report